NexusVision
NexusVision Raises $20M Seed to Transform Biotech
Quick Facts
NexusVision Raises $20M Seed in Latest Funding Round
NexusVision has successfully closed a $20M Seed funding round, marking a significant milestone in the company's growth trajectory. The round was led by Sequoia Capital, with participation from 500 Startups.
Company Overview
Founded in 2020 and headquartered in Seattle, WA, NexusVision has established itself in the Biotech space. Leading machine learning platform automating enterprise workflows with advanced AI models
With a current valuation of $100M, the company has demonstrated strong market traction and investor confidence.
Investment Details
- Amount Raised: $20M Seed
- Valuation: $100M
- Lead Investor: Sequoia Capital
Future Outlook
As NexusVision moves forward with its expanded funding, the company is well-positioned to capitalize on market opportunities and drive innovation in the biotech space.
Key Investors
About the Author
Related Company Reports
PrimeNet Raises $300M Series C to Transform Biotech
PrimeNet has secured $300M Series C in funding to accelerate growth and innovation. Leading machine learning platform automating enterprise workflows with advanced AI models...
HorizonStudio Raises $100M Growth to Transform Biotech
HorizonStudio has secured $100M Growth in funding to accelerate growth and innovation. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses...
StreamData Raises $15M Seed to Transform Biotech
StreamData has secured $15M Seed in funding to accelerate growth and innovation. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses...